SmartCella raises EUR 50 million to accelerate growth and commercialization SmartCella Holding AB (“SmartCella”) today announces a new share issue raising approximately EUR 50 million to accelerate growth and support…
AstraZenecas (AZN) Tagrisso Gets EU Nod for First-Line NSCLC The European Commission approves AstraZenecas (AZN) Tagrisso in combination with chemotherapy for first-line treatment of advanced EGFR-mutated NSCLC based on…
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use The CHMP recommends approval of AstraZenecas (AZN) Imfinzi plus Lynparza for treating primary advanced or recurrent endometrial cancer based on…
Total Voting Rights 1 July 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…